AI Drug Developer METIS TECHBIO-P Continues to Attract Market Capital, Shares Surge Over 7% Before Noon

Deep News
08/10

Hot sector self-selected stocks, data centers, market trends, capital flows, and simulated trading clients are all focusing on METIS TECHBIO-P (07666). The stock continues to attract market capital, surging over 20% in early trading and leading the AI pharmaceutical sector. As of the time of writing, gains have narrowed slightly, with the stock price rising 7.19% to 11.92 Hong Kong dollars, and a turnover of 85.1 million Hong Kong dollars.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10